Philip L McCarthy Jr
Overview
Explore the profile of Philip L McCarthy Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hahn T, McCarthy Jr P, Hassebroek A, Bredeson C, Gajewski J, Hale G, et al.
J Clin Oncol
. 2013 May;
31(19):2437-49.
PMID: 23715573
Purpose: Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases. This study describes changes in use, technique, and...
2.
McCarthy Jr P, Hahn T, Hassebroek A, Bredeson C, Gajewski J, Hale G, et al.
Biol Blood Marrow Transplant
. 2013 May;
19(7):1116-23.
PMID: 23660172
Autologous hematopoietic cell transplantation (auto-HCT) is performed to treat relapsed and recurrent malignant disorders and as part of initial therapy for selected malignancies. This study evaluated changes in use, techniques,...
3.
Oliansky D, Camitta B, Gaynon P, Nieder M, Parsons S, Pulsipher M, et al.
Biol Blood Marrow Transplant
. 2012 Apr;
18(7):979-81.
PMID: 22490784
No abstract available.
4.
Oliansky D, Camitta B, Gaynon P, Nieder M, Parsons S, Pulsipher M, et al.
Biol Blood Marrow Transplant
. 2012 Jan;
18(4):505-22.
PMID: 22209888
Clinical research published since the first evidence-based review on the role of hematopoietic stem cell transplantation (SCT) in the treatment of pediatric acute lymphoblastic leukemia (ALL) is presented and critically...
5.
Yao S, Sucheston L, Smiley S, Davis W, Conroy J, Nowak N, et al.
PLoS One
. 2011 Oct;
6(10):e25940.
PMID: 22022476
Background: Bone mineral density (BMD) loss commonly occurs after hematopoietic cell transplantation (HCT). Hypothesizing that genetic variants may influence post-HCT BMD loss, we conducted a prospective study to examine the...
6.
Oliansky D, Larson R, Weisdorf D, Dillon H, Ratko T, Wall D, et al.
Biol Blood Marrow Transplant
. 2011 Oct;
18(1):16-7.
PMID: 21963620
No abstract available.
7.
Oliansky D, Larson R, Weisdorf D, Dillon H, Ratko T, Wall D, et al.
Biol Blood Marrow Transplant
. 2011 Aug;
18(1):18-36.e6.
PMID: 21803017
Clinical research published since the first evidence-based review on the role of hematopoietic stem cell transplantation (SCT) in the treatment of acute lymphoblastic leukemia (ALL) in adults is presented and...
8.
Howard D, Kenline C, Lazarus H, LeMaistre C, Maziarz R, McCarthy Jr P, et al.
Health Serv Res
. 2011 Jul;
46(6pt1):1762-77.
PMID: 21790588
Objective: In 1999, three randomized controlled trials concluded that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HDC/HCT) is no better than conventional chemotherapy for women with breast cancer....
9.
Oliansky D, Czuczman M, Fisher R, Irwin F, Lazarus H, Omel J, et al.
Biol Blood Marrow Transplant
. 2010 Jul;
17(1):20-47.e30.
PMID: 20656046
Clinical research published since the 2001 evidence-based review on the role of hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell lymphoma (DLBCL) in adults is...
10.
Yao S, Smiley S, West K, Lamonica D, Battiwalla M, McCarthy Jr P, et al.
Biol Blood Marrow Transplant
. 2010 Mar;
16(8):1130-7.
PMID: 20188201
Bone mineral density (BMD) loss occurs commonly in patients after allogeneic hematopoietic cell transplantation (HCT), primarily because of steroid use, but little is known about BMD change post-autologous HCT. In...